TED Ted Baker Plc

    RNS Number : 9337W
  Tepnel Life Sciences PLC
  17 June 2008
   

    



               

    Distribution of Annual Report and Accounts


    17th June 2008, Tepnel Life Sciences PLC (AIM: TED), the international Molecular Diagnostics and Research Products & Services group, is
pleased to announce that it has distributed its Annual Report and Accounts for the year ended 31st December 2007 to shareholders today.  The
Annual Report will be available on Tepnel's Investor Relations website in due course.



    -Ends-

    For further information:

    Tepnel Life Sciences plc
    Ben Matzilevich, CEO
    Michael Slater
    Tel: 0161 946 2200

    Capital MS&L
    Mary Clark or Joanna Whineray
    Tel: +44 20 7307 5330



    Notes to Editors:

    About Tepnel Life Sciences plc
    Tepnel Life Sciences (AIM:TED) is a UK-based international life sciences products and services Group with two divisions, Molecular
Diagnostics and Research Products & Services. The Company has laboratories, manufacturing and operations in the USA, UK and France with over
200 employees. Tepnel provides test kits, reagents and services to two highly synergistic markets, these being Molecular Diagnostics and
Biomedical Research. The Company's strategy has been to identify high growth niche opportunities within these multi-billion pound markets.
Tepnel focuses on these niche operations with internally developed products, patents, expertise and know-how as well as strategic
acquisitions, to develop a leadership position within these 
This information is provided by RNS
The company news service from the London Stock Exchange
 
  END 
 
ACSFKOKDPBKDPAD

Ted Baker (LSE:TED)
Historical Stock Chart
From Jun 2024 to Jul 2024

Ted Baker (LSE:TED)
Historical Stock Chart
From Jul 2023 to Jul 2024